Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Preferred Stock Liabilities (2017 - 2023)

Q32 Bio (QTTB) has 3 years of Preferred Stock Liabilities data on record, last reported at $111.4 million in Q4 2023.

  • For Q4 2023, Preferred Stock Liabilities changed N/A year-over-year to $111.4 million; the TTM value through Dec 2023 reached $111.4 million, changed N/A, while the annual FY2023 figure was $111.4 million, N/A changed from the prior year.
  • Preferred Stock Liabilities reached $111.4 million in Q4 2023 per QTTB's latest filing, down from $137.8 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $111.4 million in Q4 2023 and bottomed at $111.4 million in Q4 2023.